Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...

This is just a glimpse of the GLP-1 trends available to CivicScience clients. Want to see the full picture? Let’s talk.

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss.  GLP-1 medications were originally intended to ...

McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

As obesity rates in the United States have reached 41.9 percent among adults, Xevant has released a new e-book, Navigating Obesity Care and GLP-1 Coverage: A Guide for Employers, designed to empower ...